Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felicitas Hitz

Showing results (11-20 of 55) with videos related to

Pageof 6
Sort By:
Swiss Medical Weekly|November 15, 2013
Diagnosis and treatment of mantle cell lymphomaFelicitas Hitz, Mario Bargetzi, Sergio Cogliatti, et al.
Hematological Oncology|April 23, 2015
Improved survival of older patients with multiple myeloma in the era of novel agentsUlrich J M Mey, Christoph Leitner, Christoph Driessen, et al.
Hematological Oncology|May 16, 2022
Outcome of older myeloma patients in relationship to comorbidities and availability of second-generation novel agents in a real-life settingMurielle Lalive d'Epinay, Sabine Güsewell, Nicole Graf, et al.
Swiss Medical Weekly|February 1, 2012
Diagnosis and treatment of diffuse large B-cell lymphomaUlrich Mey, Felicitas Hitz, Andreas Lohri, et al.
Cancer Reports (Hoboken, N.J.)|September 28, 2021
Team functioning across different tumour types: Insights from a Swiss cancer center using qualitative and quantitative methodsFelicitas Hitz, Karin Ribi, Gudela Grote, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 14, 2017
Cancer-specific geriatric assessment and quality of life: important factors in caring for older patients with aggressive B-cell lymphomaKarin Ribi, Stéphanie Rondeau, Felicitas Hitz, et al.
BMC Medical Informatics and Decision Making|August 27, 2013
The SAKK cancer-specific geriatric assessment (C-SGA): a pilot study of a brief tool for clinical decision-making in older cancer patientsKerri M Clough-Gorr, Lea Noti, Peter Brauchli, et al.
Swiss Medical Weekly|August 5, 2011
Diagnosis and treatment of follicular lymphomaFelicitas Hitz, Nicolas Ketterer, Andreas Lohri, et al.
Annals of Hematology|August 7, 2015
Outcome of patients with primary refractory diffuse large B cell lymphoma after R-CHOP treatmentFelicitas Hitz, J M Connors, R D Gascoyne, et al.
Leukemia & Lymphoma|August 19, 2021
A phase I trial of inotuzumab ozogamicin in combination with temsirolimus in patients with relapsed or refractory CD22-positive B-cell non-Hodgkin lymphomasMaria C Pirosa, Lu Zhang, Felicitas Hitz, et al.
Pageof 6

Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
Swiss Medical Weekly|November 15, 2013
Diagnosis and treatment of mantle cell lymphomaFelicitas Hitz, Mario Bargetzi, Sergio Cogliatti, et al.
Hematological Oncology|April 23, 2015
Improved survival of older patients with multiple myeloma in the era of novel agentsUlrich J M Mey, Christoph Leitner, Christoph Driessen, et al.
Hematological Oncology|May 16, 2022
Outcome of older myeloma patients in relationship to comorbidities and availability of second-generation novel agents in a real-life settingMurielle Lalive d'Epinay, Sabine Güsewell, Nicole Graf, et al.
Swiss Medical Weekly|February 1, 2012
Diagnosis and treatment of diffuse large B-cell lymphomaUlrich Mey, Felicitas Hitz, Andreas Lohri, et al.
Cancer Reports (Hoboken, N.J.)|September 28, 2021
Team functioning across different tumour types: Insights from a Swiss cancer center using qualitative and quantitative methodsFelicitas Hitz, Karin Ribi, Gudela Grote, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 14, 2017
Cancer-specific geriatric assessment and quality of life: important factors in caring for older patients with aggressive B-cell lymphomaKarin Ribi, Stéphanie Rondeau, Felicitas Hitz, et al.
BMC Medical Informatics and Decision Making|August 27, 2013
The SAKK cancer-specific geriatric assessment (C-SGA): a pilot study of a brief tool for clinical decision-making in older cancer patientsKerri M Clough-Gorr, Lea Noti, Peter Brauchli, et al.
Swiss Medical Weekly|August 5, 2011
Diagnosis and treatment of follicular lymphomaFelicitas Hitz, Nicolas Ketterer, Andreas Lohri, et al.
Annals of Hematology|August 7, 2015
Outcome of patients with primary refractory diffuse large B cell lymphoma after R-CHOP treatmentFelicitas Hitz, J M Connors, R D Gascoyne, et al.
Leukemia & Lymphoma|August 19, 2021
A phase I trial of inotuzumab ozogamicin in combination with temsirolimus in patients with relapsed or refractory CD22-positive B-cell non-Hodgkin lymphomasMaria C Pirosa, Lu Zhang, Felicitas Hitz, et al.
Pageof 6